PEN - Penumbra Inc
Close
240.71
0.615 0.255%
Share volume: 7,390
Last Updated: Thu 26 Dec 2024 08:30:04 PM CET
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
$240.10
0.62
0.26%
Fundamental analysis
19%
Profitability
16%
Dept financing
26%
Liquidity
58%
Performance
10%
Performance
5 Days
-0.08%
1 Month
-3.45%
3 Months
25.43%
6 Months
37.49%
1 Year
-7.60%
2 Year
9.52%
Key data
Stock price
$240.71
DAY RANGE
$238.15 - $241.28
52 WEEK RANGE
$170.13 - $277.34
52 WEEK CHANGE
-$5.91
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Adam Elsesser
Region: US
Website: penumbrainc.com
Employees: 3,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: penumbrainc.com
Employees: 3,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.
Recent news